Radio and PodcastRadio and PodcastLive Radio & Podcasts
ONCOLOGY: Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide artwork
Science & Medicine

ONCOLOGY: Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide

Audio Medica News - Medical News Interviews by Audio Medica

Dec 14, 200700:05:02Science & Medicine

Oncology, December 13th, 2007 Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007 Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide STEPHEN JONES, US Oncology Research, H...